|
RDX expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32590000004418E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.263800E-02 |
| Normal-vs-Stage2 |
2.808600E-01 |
| Normal-vs-Stage3 |
1.01949999553597E-08 |
| Normal-vs-Stage4 |
1.75710000005491E-06 |
| Stage1-vs-Stage2 |
8.906000E-01 |
| Stage1-vs-Stage3 |
9.95069999999432E-05 |
| Stage1-vs-Stage4 |
8.644700E-04 |
| Stage2-vs-Stage3 |
5.483500E-02 |
| Stage2-vs-Stage4 |
6.839900E-02 |
| Stage3-vs-Stage4 |
9.987200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.81780000000553E-05 |
| Normal-vs-AfricanAmerican |
1.04759999997039E-06 |
| Normal-vs-Asian |
9.535400E-01 |
| Caucasian-vs-AfricanAmerican |
1.784210E-02 |
| Caucasian-vs-Asian |
4.250200E-01 |
| AfricanAmerican-vs-Asian |
6.206000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1139000000735E-07 |
| Normal-vs-Female |
1.688310E-02 |
| Male-vs-Female |
6.272400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.235900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.875800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.88299999998232E-06 |
| Normal-vs-Age(81-100Yrs) |
1.252160E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.819560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.801600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.814200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.540400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.708400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.097600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.951800E-01 |
| Normal-vs-Grade 2 |
1.048590E-01 |
| Normal-vs-Grade 3 |
2.62689999996901E-06 |
| Normal-vs-Grade 4 |
1.50249812591596E-11 |
| Grade 1-vs-Grade 2 |
4.042600E-01 |
| Grade 1-vs-Grade 3 |
5.029500E-02 |
| Grade 1-vs-Grade 4 |
3.582700E-04 |
| Grade 2-vs-Grade 3 |
1.004350E-02 |
| Grade 2-vs-Grade 4 |
5.15770000042437E-08 |
| Grade 3-vs-Grade 4 |
5.404600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.176370E-01 |
| Normal-vs-ccB subtype |
1.76014758324072E-12 |
| ccA subtype-vs-ccB subtype |
1.62481139653892E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.36369999999853E-05 |
| Normal-vs-N1 |
2.702300E-02 |
| N0-vs-N1 |
2.515200E-01 |
|
|
